This article provides important information about the updated COVID-19 vaccines and their recommendations for older adults and individuals with weakened immune systems. It highlights the continued risk of COVID-19, particularly for vulnerable populations, and emphasizes the crucial role of vaccination in reducing the severity of illness.
Kim, as Health yWomen's editorial director, manages all content production, ensuring it aligns with the organization's mission, adheres to high editorial standards, and reflects the brand voice. Kim is an award-winning editor and copywriter with over 25 years of experience. Her career began as a copywriter and broadcast producer at The Tombras Group, the Southeast's largest full-service advertising agency.
Since then, she has collaborated with diverse clients, spanning Fortune 500 companies to independent authors across various industries and subject matters. Kim holds a bachelor's degree in communications from the University of North Carolina, Chapel Hill, and a master's degree in advertising from the University of Tennessee, Knoxville. While the pandemic's official declaration is over, COVID-19 continues to affect many individuals. The virus poses a heightened risk for adults aged 65 and older, as well as those with moderately or severely weakened immune systems, increasing their susceptibility to severe illness and hospitalization. Fortunately, vaccines significantly reduce the likelihood of infection and, if infection occurs, mitigate the risk of serious complications, long COVID, and hospitalization. All previously vaccinated adults should receive one dose of the updated 2024-2025 COVID vaccine. Notably, the Advisory Committee on Immunization Practices (ACIP) recommends additional doses for adults aged 65 and older and immunocompromised individuals over 6 months old. This includes adults aged 65 and older, regardless of their vaccination history, and individuals between 6 months and 64 years with moderate or severe immunodeficiency. For these individuals, the recommended regimen involves two Novavax doses as part of the initial series, with the second dose administered 2-6 months after the first. Individuals with certain health conditions, such as those undergoing solid organ transplants or taking immunosuppressive medications, are at a higher risk of experiencing severe COVID-19 illness. Consulting with a healthcare provider to determine if you are immunocompromised and the appropriate number of COVID vaccine doses is crucial. Some moderately or severely immunocompromised individuals may be eligible for a preventive monoclonal antibody called pemivibart. Discussing this option with your healthcare provider can help determine its suitability. However, it's essential to emphasize that monoclonal antibody treatment should not supersede vaccination
COVID-19 Vaccines Older Adults Immunocompromised Health Recommendations Severe Illness
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Dragon Ball Sparking Zero!: Downtime for 1/20 Update - New Characters, FREE Update, & MoreDragon Ball: Sparking Zero has had a rocky few months. Though many characters were released in a state that some fans considered unacceptable, there's no denyin
Read more »
COVID-19 cases drop for second week: Coronavirus update for Thursday, Jan. 16, 2025At least 1,164,564 Ohioans have received the new 2024-2025 updated vaccine COVID-19 vaccine, an increase of 22,156 from the prior week, the state reported.
Read more »
Penn's COVID-19 Vaccine Royalties Reach $2 BillionThe University of Pennsylvania has secured at least $2 billion in royalties from the Pfizer-BioNTech COVID-19 vaccine through a new settlement with BioNTech.
Read more »
Jersey Holds Pop-Up Vaccine Clinics for Flu and COVIDThe Jersey government is encouraging eligible residents to receive their flu and COVID-19 vaccinations through pop-up clinics due to rising case numbers.
Read more »
Moderna Shares Drop as COVID Vaccine Sales DeclineModerna's stock price plummeted on Monday after the company predicted a sharp drop in sales for its COVID-19 vaccine in the coming year.
Read more »
Families of Vaccine-Injured Speak Out at UK Covid InquiryFamilies impacted by COVID-19 vaccines shared their experiences with the UK Covid Inquiry, highlighting the lack of support and the long-lasting consequences of vaccine injuries. They emphasized the urgent need to address the issue and the importance of considering the full picture of vaccine effects.
Read more »